Description
Description: Glucowellmet 50/500MG Tablets combine Vildagliptin and Metformin to manage type 2 diabetes mellitus. Vildagliptin enhances the release of insulin and reduces glucagon secretion, while Metformin improves insulin sensitivity and decreases glucose production in the liver. This combination helps achieve better glycemic control.
Dosage/Directions: The usual dose is one tablet taken twice daily with meals to minimize gastrointestinal discomfort. Dosage adjustments may be necessary based on blood sugar levels and individual response. It is important to follow the healthcare provider’s instructions and not to exceed the prescribed dose.
Side Effects: Common side effects include gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal pain. Hypoglycemia (low blood sugar) can occur, especially when combined with other antidiabetic medications. Other potential side effects include headache, dizziness, and upper respiratory tract infections. Consult a healthcare provider if severe side effects occur.
